Market Trends of Muscle Stimulator Industry
Neurological Disorders Segment is Expected to Have a Significant Market Share During the Forecast Period
Neurological disorders, such as Parkinson's disease, dystonia, dementia, and Alzheimer's disease, are often treated with the help of electrical stimulators. Factors such as the rising prevalence of neurological diseases and the rising usage of muscle stimulators for the treatment of neurological conditions are expected to boost segment growth.
For instance, according to an article published by the International Parkinson and Movement Disorder Society in July 2022, a study was conducted in Sweden, which showed that the pooled prevalence of cervical dystonia was 11.75 per 100,000 people in Sweden. Thus, the high prevalence of dystonia in such countries is expected to boost segment growth.
Furthermore, according to an article published by Frontiers in January 2023, a study was conducted in Argentina, which showed that there was a normal decline in spatial memory related to aging in older people, and this dramatically increased in neuropathological conditions such as Alzheimer's disease (AD). This indicates that the high burden of Alzheimer's Disease (AD) in the elderly population of the country is expected to create opportunities for market players to market electrical stimulator devices for the early screening and treatment of AD, thereby propelling market growth. Moreover, the rising research funding for neurological disorders is also expected to boost segment growth, as it will help in the development of new electric stimulators.
Hence, the aforementioned factors, such as the rising prevalence of various neurological disorders, are expected to boost the segment’s growth during the forecast period.
North America is Expected to Hold a Significant Share in the Market in the Forecast Period
North America is expected to hold a significant market share due to the growing healthcare expenditure for innovation and development of medical devices, increasing musculoskeletal disorders, and the presence of a well-established healthcare infrastructure.
The increasing prevalence of neurological and musculoskeletal diseases is expected to contribute to market growth over the forecast period. For instance, according to an article published by ScienceDirect in March 2022, a study was conducted in Mexico which showed that the prevalence rate of Parkinson's disease in the urban parts of Mexico ranged from 2.1% in the 65 to 69-year-old age group to 11.9% in 75 to 79-year-old age group. Thus, the high prevalence of Parkinson's disease in the country is expected to boost segment growth.
Furthermore, product launches in the region are also expected to boost market growth. For instance, in November 2023, NeuroTrigger announced that its non-invasive muscle stimulation system (NTB) had been granted 510(k) clearance by the US Food and Drug Administration (FDA) for the prevention or retardation of disuse atrophy and muscle re-education to maintain or increase range of motion. The NTB system is portable, rechargeable, aesthetic, and user-friendly and is composed of three elements: a stimulator, a daily use/disposable electrode, and a mobile app, all of which control the system.
Thus, the abovementioned factors, such as the rising prevalence of various neurological diseases and the increasing product launches, are expected to accelerate market growth in the region during the forecast period.
